-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ULD/flIfDzQ4Lmo1eNjKZk139CMW2kQ7AaGJ2KooTMzN3ZaHSjb0RFgCpGJx6txk gRPKgwtLrtr53d5pIyrPDg== 0001179110-08-000878.txt : 20080109 0001179110-08-000878.hdr.sgml : 20080109 20080109095247 ACCESSION NUMBER: 0001179110-08-000878 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080107 FILED AS OF DATE: 20080109 DATE AS OF CHANGE: 20080109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRUKER BIOSCIENCES CORP CENTRAL INDEX KEY: 0001109354 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 043110160 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 MAIL ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 FORMER COMPANY: FORMER CONFORMED NAME: BRUKER DALTONICS INC DATE OF NAME CHANGE: 20000315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DROSS DANIEL CENTRAL INDEX KEY: 0001218921 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30833 FILM NUMBER: 08519384 MAIL ADDRESS: STREET 1: 5465 E CHERYL PKWY CITY: MADISON STATE: WI ZIP: 53719 4 1 edgar.xml FORM 4 - X0202 4 2008-01-07 0 0001109354 BRUKER BIOSCIENCES CORP BRKR 0001218921 DROSS DANIEL 4433 MCFARLIN BLVD. DALLAS TX 75205 1 0 0 0 Stock Option (Right to Buy) 12.09 2008-01-07 4 A 0 6000 0 A 2009-01-07 2018-01-07 Common Stock 6000 6000 D The option vests in three equal annual installments on the anniversary of the grant date, begining on January 7, 2009. /s/Constance Andrews, Attorney-in-Fact 2008-01-09 EX-24 2 ex24dross.txt Exhibit 24 POWER OF ATTORNEY Know all by these present that the undersigned hereby constitutes and appoints each of Constance Andrews and Brian Monahan of Bruker BioSciences Corporation, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of Bruker BioSciences Corporation (the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney- in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in- fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 23rd day of March, 2007. /s/Daniel S. Dross WITNESS: /s/Deborah D. Reed March 23, 2007 -----END PRIVACY-ENHANCED MESSAGE-----